| 臺大學術典藏 |
2020-05-25T07:35:28Z |
Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.
|
Shao Y.Y; Chia-Chi Lin; Yang C.H. |
| 臺大學術典藏 |
2020-05-25T07:35:28Z |
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors
|
Chia-Chi Lin; Hsu H.-H; Sun C.-T; Shih J.-Y; Lin Z.-Z; Yu C.-J; Chen G.G; Hsin M.K.Y; Lam K.C; Leung L; Yang C.-H; Mok T. |
| 臺大學術典藏 |
2020-05-25T06:52:11Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C; Yang C.-H; YEN-SHEN LU; Lin C.-C; Bu C.-F; Yeh K.-H.; Yeh K.-H.;Bu C.-F;Lin C.-C;Yen-Shen Lu;Yang C.-H;Hsu C;Cheng A.-L;Hsu C.-H; Hsu C.-H; Cheng A.-L |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Phase II study of combination doxorubicin, interferon-�\, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Cheng A.-L.;Wu C.-Y;Hsu C.-H;Yang C.-H;Yeh K.-H;Kuo S.-H;Li C.-C;Hsu C;Yen-Shen Lu; YEN-SHEN LU; Hsu C; Li C.-C; Kuo S.-H; Yeh K.-H; Yang C.-H; Hsu C.-H; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.;Wu C.-Y;Chen J.-S;Li C.-C;Liu H.-T;Hsu C.-H;Yen-Shen Lu;Yeh K.-H;Yang C.-H;Shen Y.-C;Hsu C; Hsu C; Shen Y.-C; Yang C.-H; Yeh K.-H; YEN-SHEN LU; Hsu C.-H; Liu H.-T; Li C.-C; Chen J.-S; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:09Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh K.H;Yen-Shen Lu;Hsu C.H;Lin J.F;Chao H.J;Huang T.C;Chung C.Y;Chang C.S;Yang C.H;Cheng A.L.; Yeh K.H; YEN-SHEN LU; Hsu C.H; Lin J.F; Chao H.J; Huang T.C; Chung C.Y; Chang C.S; Yang C.H; Cheng A.L. |
| 臺大學術典藏 |
2020-05-25T06:52:07Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C;Cheng A.-L;Hsu C.-H;Yen-Shen Lu;Hsu C;Yeh K.-H;Wu C.-Y;Huang C.-S;Yang C.-H.; Lin C.-C; Cheng A.-L; Hsu C.-H; YEN-SHEN LU; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; Yang C.-H. |
| 臺大學術典藏 |
2020-05-25T06:52:02Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu P.-F;Kuo K.-T;Kuo L.-T;Lin Y.-T;Lee W.-C;Yen-Shen Lu;Yang C.-H;Wu R.-M;Tu Y.-K;Tasi J.-C;Tseng H.-M;Tseng S.-H;Cheng A.-L;Lin C.-H.; Wu P.-F; Kuo K.-T; Kuo L.-T; Lin Y.-T; Lee W.-C; YEN-SHEN LU; Yang C.-H; Wu R.-M; Tu Y.-K; Tasi J.-C; Tseng H.-M; Tseng S.-H; Cheng A.-L; Lin C.-H. |
| 臺大學術典藏 |
2020-05-25T06:51:53Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H;Shen C.-Y;Lee J.-H;Huang C.-S;Yang C.-H;Kuo W.-H;Chang D.-Y;Hsiung C.-N;Kuo K.-T;Chen W.-W;Chen I.-C;Wu P.-F;Kuo S.-H;Chen C.-J;Yen-Shen Lu;Cheng A.-L.; Lin C.-H; Shen C.-Y; Lee J.-H; Huang C.-S; Yang C.-H; Kuo W.-H; Chang D.-Y; Hsiung C.-N; Kuo K.-T; Chen W.-W; Chen I.-C; Wu P.-F; Kuo S.-H; Chen C.-J; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T02:46:08Z |
Application of deep learning image assessment software VeriSee? for diabetic retinopathy screening
|
Hsieh Y.-T.;Chuang L.-M.;Jiang Y.-D.;Tien-Jyun Chang;Yang C.-M.;Yang C.-H.;Chan L.-W.;Kao T.-Y.;Chen T.-C.;Lin H.-C.;Tsai C.-H.;Chen M.; Hsieh Y.-T.; Chuang L.-M.; Jiang Y.-D.; TIEN-JYUN CHANG; Yang C.-M.; Yang C.-H.; Chan L.-W.; Kao T.-Y.; Chen T.-C.; Lin H.-C.; Tsai C.-H.; Chen M. |
| 臺大學術典藏 |
2020-05-15T07:01:33Z |
Scenario analysis on operational productivity for target EGS reservoir in I-lan area, Taiwan
|
Yu, C.-W.; Lei, S.-C.; Yang, C.-H.; Chen, W.-S.; Song, S.-R.; WEN-SHAN CHEN |
| 臺大學術典藏 |
2020-05-05T08:40:28Z |
A novel DNA selection and direct extraction process and its application in DNA recombination
|
Wang A.-B.; Cheng C.-W.; Lin I.-C.; Lu F.-Y.; Tsai H.-J.; Lin C.-C.; Yang C.-H.; Pan P.-T.; Kuan C.-C.; Chen Y.-C.; Lin Y.-W.; Chang C.-N.; Wu Y.-H.; Kurniawan T.; Lin C.-W.; Wo A.M.; Chen L.-C.; AN-BANG WANG |
| 臺大學術典藏 |
2020-04-28T07:25:38Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Chih-Hung Hsu;Cheng A.-L.;Hsu C.;Yang C.-H.;Lu Y.-S.;Lin C.-C.;Bu C.-F.;Yeh K.-H.; CHIH-HUNG HSU; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:37Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
CHIH-HUNG HSU; Wu C.-Y.; Cheng A.-L.; Lu Y.-S.;Hsu C.;Li C.-C.;Kuo S.-H.;Yeh K.-H.;Yang C.-H.;Chih-Hung Hsu;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:36Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang C.-H.; Chen M.-C.; Cheng A.-L.; CHIH-HUNG HSU; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C.; Yang C.-H.;Chen M.-C.;Cheng A.-L.;Chih-Hung Hsu;Yeh K.-H.;Yu Y.-C.;Whang-Peng J.;Yang P.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:31Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
CHIH-HUNG HSU;Cheng A.-L.;Hsu W.-L.;Tsai Y.-C.;Hsu C.;Yang C.-H.;Yeh K.-H.;Lin C.-C.; Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2020-04-28T07:25:30Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.; CHIH-HUNG HSU; Yu C.-J.; Chang Y.-C.; Hsu C.; Yang C.-H.;Yang P.-C.;Cheng A.-L.;Lin C.-C.;CHIH-HUNG HSU;Yu C.-J.;Chang Y.-C.;Hsu C.;Lin Z.-Z.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-04-28T07:12:14Z |
Injecting charges on large-area electret thin film by corona multi-pin discharge method
|
Su, Y.-H.; Chung, C.-E.; Ko, W.-C.; Yang, C.-H.; Wu, W.-J.; Lee, C.-K.; CHIH-KUNG LEE; Su, Y.-H.;Chung, C.-E.;Ko, W.-C.;Yang, C.-H.;Wu, W.-J.;Lee, C.-K. |
| 臺大學術典藏 |
2020-04-28T07:11:16Z |
A planar interdigitated ring electrode array via dielectrophoresis for uniform patterning of cells
|
Hsiung, L.-C.; Yang, C.-H.; Chiu, C.-L.; Chen, C.-L.; Wang, Y.; Lee, H.; Cheng, J.-Y.; Ho, M.-C.; Wo, A.M.; ANDREW WO |
| 臺大學術典藏 |
2020-04-27T12:34:28Z |
Thermopneumatic suction integrated microfluidic blood analysis system
|
Li, B.-R.;Tsou, P.-H.;Hsieh, Y.-L.;Yang, C.-H.; Yang, C.-H.; Hsieh, Y.-L.; Tsou, P.-H.; Li, B.-R. |
| 臺大學術典藏 |
2020-04-10T12:51:32Z |
MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer
|
Chiun Hsu; Yeh K.-H.; Hong R.-L.; Yang C.-H.; Lin M.-T.; Chen Y.-C.; Cheng A.-L.; Chiun Hsu;Yeh K.-H.;Hong R.-L.;Yang C.-H.;Lin M.-T.;Chen Y.-C.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:31Z |
Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer
|
Yang C.H.;Tsai C.M.;Wang L.S.;Lee Y.C.;Chang C.J.;Lui L.T.;Yen S.H.;Chiun Hsu;Cheng A.L.;Liu M.Y.;Chiang S.C.;Chen Y.M.;Luh K.T.;Huang M.H.;Yang P.-C.;Perng R.-P.; Perng R.-P.; Yang P.-C.; Luh K.T.; Huang M.H.; Chen Y.M.; Chiang S.C.; Liu M.Y.; Cheng A.L.; Chiun Hsu; Tsai C.M.; Wang L.S.; Lee Y.C.; Chang C.J.; Lui L.T.; Yen S.H.; Yang C.H. |
| 臺大學術典藏 |
2020-04-10T12:51:29Z |
Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13
|
Chie W.-C.;Yang C.-H.;Chiun Hsu;Yang P.-C.; Chie W.-C.; Yang C.-H.; Chiun Hsu; Yang P.-C. |
| 臺大學術典藏 |
2020-04-10T12:51:29Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; Cheng A.-L.; Lu Y.-S.;Chiun Hsu;Li C.-C.;Kuo S.-H.;Yeh K.-H.;Yang C.-H.;Hsu C.-H.;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Chiun Hsu |
| 臺大學術典藏 |
2020-04-10T12:51:28Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H.;Yang C.-H.;Yu C.-J.;Chiun Hsu;Cheng A.-L.;Yang P.-C.; Kuo S.-H.; Yang C.-H.; Yu C.-J.; Chiun Hsu; Cheng A.-L.; Yang P.-C. |
